Socioeconomic impact of haemophilia care: Results of a pilot study

Haemophilia

Volumn 2, Issue 4, 1996, Pages 211-217

  Szucs, T D ^a   Offner A ^a   Schramm, W ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE;

ADULT; ARTICLE; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH STATUS; HEMARTHROSIS; HEMOPHILIA; HUMAN; MALE; PAIN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; SOCIOECONOMICS;

EID: 0029794224     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.1996.tb00139.x     Document Type: Article

References (27)

1. Grandidier L. Die Hämophilie oder die Bluterkrankheit. Leipzig Wiegand: 1877.
2. Lechner K. Handbuch der Inneren Medizin, Vol. II/9. Berlin: 1985.
3. Drummond M, Brandt A, Luce B, Rovira J. Standardising methodologies for economic evaluation in health care. Practice, problems, and potential. Int J Technol Ass Health Care, 1993; 9: 26-36.
4. Luce BR, Elixhauser A. Standards for the Socioeconomic Evaluation of Health Care Services. Berlin: Springer, 1990.
5. Drummond MF, Stoddard GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford Medical Publications, 1987.
6. Kaplan R, Bush J. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychology, 1982; 1: 61-80.
7. Feeny D, Torrance GW. Utilities and quality-adjusted life years. Int J Technol Ass Healthcare, 1989; 5: 559-75.
8. Kamps BS, Brodt HR, Staszewski S. Bergman L, Helm EB. AIDS-free survival and overall survival in HIV infection: the new CDC classification system (1993). Clin Investig, 1994; 72: 283-7.
9. Gilbert MS. Prophylaxis. Musculoskeleteral evaluation. Semin Hematol, 1993; 30: Suppl 2, 3-6.
10. Pettersson H. Radiographic score and implications. Semin Hematol, 1995: 30: Suppl 2, 7-11.
11. Ware JE, Sherbourne CD. The MOS 36-item shortform health survey [SF-36]. Conceptual framework and item selection. Med Care, 1992; 30: 473-83.
12. Bullinger M, Kirchberger I, Ware J. Der deutsche SF-36 Health Survey. Institut für Medizinische Psychologie, LMU, 1994.
13. Ware JE. SF-36 Health Survey, Manual Interpretation Guide, 1993. Boston: The Medical Outcomes Trust, 1993.
14. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Economics, 1986; 5: 1-30.
15. Anon. Einheitlicher Bewertungsmasstab für Ärztliche Leistungen. Bonn, 1996.
16. Red List (Rote Liste). Aulendorff: Bundesverband der Pharmazeutischen Industrie, 1996.
17. Statistisches Jahrbuch der Bundesrepublik Deutschland. Wiesbaden: Statistische Bundesamt, 1996.
18. Bergstrom TC. When is a man's life worth more then his human capital? In: Jones-Lee MW, ed. The Value of Life and Safety, Amsterdam: North Holland, 1982; 3-26.
19. Robinson R. Cost-effectiveness analysis. Brit Med J, 1993; 307: 793-5.
20. Nilsson IM, Berntorp E, Löfqvist T, Pettersson H: Twenty-five years experience of prophylactic treatment in severe haemophilia A and B. J Int Med 1992; 232: 25-32.
21. Aledort LM, Haschmeyer RH, Pattersson H. The Orthopedic Outcomes Study Group. A longitudinal study of orthopedic outcomes for severe factor VIII deficient hemophilia. J Intern Med 1994; 236: 391-9.
22. Schramm W. Factor VIII purity and prophylaxis: experience with prophylactic treatment in Germany. Royal Soc Medicine Services Round Table Series, 1991; 25.
23. O'Meara JJ, et al. A decision analysis of steptokinase plus heparin as compared with heparin alone for deep venous thrombosis. N Engl J Med, 1994; 330: 1864-9.
24. Kassirer JP. Incorporating patients' preferences into medical decisions. N Engl J Med, 1994; 330: 1895-6.
25. Detsky AS. Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada. PharmacoEcon, 1993; 3: 354-61.
26. Buxton MJ, Drummond MF, Hout BA, Prince RL, Sheldon TA, Szucs T, Vray M. Modelling in economic evaluation. A first and last resort?. J Clin Eptdemiol, in press.
27. Institute of Medicine. Guidelines for Clinical Practice. From Development to Use. Washington: National Academy Press, 1992.